Wouter W. Mellema

EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases?

Lizza Hendriks, Egbert F. Smit, Bettine A.H. Vosse et al. · Lung Cancer · 2014 · 117 citations · Full text

Brain Metastases, Medicine, Pathology +8

Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation

Floris H. Groenendijk, Wouter W. Mellema, Eline van der Burg et al. · International Journal of Cancer · 2014 · 75 citations · Full text

Chemoprevention Strategy, Cancer Biology, Tumor Biology +22

A Phase II Study of Sorafenib in Patients with Platinum-Pretreated, Advanced (Stage IIIb or IV) Non–Small Cell Lung Cancer with a <i>KRAS</i> Mutation

Anne‐Marie C. Dingemans, Wouter W. Mellema, Harry J.M. Groen et al. · Clinical Cancer Research · 2012 · 73 citations · Full text

KRAS Mutations in Advanced Nonsquamous Non–Small-Cell Lung Cancer Patients Treated with First-Line Platinum-Based Chemotherapy Have No Predictive Value

Wouter W. Mellema, Anne‐Marie C. Dingemans, Erik Thunnissen et al. · Journal of Thoracic Oncology · 2013 · 43 citations · Full text

Kras Mutations, Medicine, Pathology +9

Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer

Wouter W. Mellema, Lucie Masen-Poos, Egbert F. Smit et al. · Lung Cancer · 2015 · 35 citations · Full text

Different Types, Medicine, Pathology +7